Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | XIAP | P98170 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.49 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.46 |
| ▸ | ANPEP | P15144 | 2/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.46 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylalanine SCHEMBL6130121 | 0.90 | SLC7A5 (0.61) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Phenylalanine SCHEMBL9216397 | 0.89 | SLC7A5 (0.59) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL1821153 | 0.88 | SLC7A5 (0.59) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL18067508 | 0.88 | ALPI (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL2723492 | 0.88 | SLC7A5 (0.54) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL222259 | 0.86 | MMP2 (0.46) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL14434512 | 0.85 | ERAP2 (0.44) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Phenylalanine SCHEMBL6130124 | 0.85 | SLC7A5 (0.51) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL5434911 | 0.84 | ALPI (0.61) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL1323648 | 0.84 | ALPI (0.59) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220034892-A1 | Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer | Metabolomycs, Inc. (US) | 2022-02-03 | — | — | US | disclosed |
| US-20220034893-A1 | Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer | Metabolomycs, Inc. (US) | 2022-02-03 | — | — | US | disclosed |
| US-11181525-B2 | Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer | Metabolomyes, Inc. (US) | 2021-11-23 | — | — | US | disclosed |
| US-11181524-B2 | Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer | METABOLOMYCS, INC (US) | 2021-11-23 | — | — | US | disclosed |
| US-20210190785-A1 | Biomarkers for Assessing Breast Cancer | BIOCRATES LIFE SCIENCE AG (AT) | 2021-06-24 | — | — | US | disclosed |
| EP-3806719-A1 | METABOLOMIC SIGNATURES FOR PREDICTING, DIAGNOSING, AND PROGNOSING VARIOUS DISEASES INCLUDING CANCER | Metabolomycs, Inc. (US) | 2021-04-21 | — | — | EP | disclosed |
| US-10962542-B2 | Biomarkers for assessing breast cancer | Metabolomycs, Inc. | 2021-03-30 | — | — | US | disclosed |
| US-20210003578-A1 | Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer | Metabolomycs, Inc. (US) | 2021-01-07 | — | — | US | disclosed |
| US-20200200754-A1 | Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer | Metabolomycs, Inc. (US) | 2020-06-25 | — | — | US | disclosed |
| EP-3191845-B1 | BIOMARKERS FOR ASSESSING BREAST CANCER | IDCGS CLINICA DE DIAGNOSTICOS MEDICOS LTDA (BR) | 2019-10-23 | — | — | EP | disclosed |
| WO-1997039126-A1 | NOVEL RANTES HOMOLOG FROM PROSTATE | INCYTE PHARMACEUTICALS, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1997038100-A1 | HUMAN CACHEXIA ASSOCIATED PROTEIN | INCYTE PHARMACEUTICALS, INC. (US) | 1997-10-16 | — | — | WO | disclosed |
| WO-1997035989-A2 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASE | INCYTE PHARMACEUTICALS, INC. (US) | 1997-10-02 | — | — | WO | disclosed |
| WO-1997035006-A1 | HUMAN CELL DEATH-ASSOCIATED PROTEIN | INCYTE PHARMACEUTICALS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |
| US-5663059-A | POLYNUCLEOTIDE WITH CODE, GENE EXPRESSION | INCYTE PHARMACEUTICALS, INC. (US) | 1997-09-02 | — | — | US | disclosed |
| WO-1997030157-A1 | NOVEL HUMAN MYELOID TERMINAL DIFFERENTIATION RESPONSE GENE | INCYTE PHARMACEUTICALS, INC. (US) | 1997-08-21 | — | — | WO | disclosed |
| US-5648238-A | GENETIC ENGINEERING | INCYTE PHARMACEUTICALS, INC. (US) | 1997-07-15 | — | — | US | disclosed |
| US-5648239-A | DIAGNOSIS | INCYTE PHARMACEUTICALS, INC. (US) | 1997-07-15 | — | — | US | disclosed |
| WO-1997024441-A1 | NUCLEIC ACIDS ENCODING INTERFERON GAMMA INDUCING FACTOR-2 | INCYTE PHARMACEUTICALS, INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997024437-A1 | NOVEL POLYNUCLEOTIDES PANC1A AND PANC1B ASSOCIATED WITH PANCREATIC CANCER | INCYTE PHARMACEUTICALS, INC. (US) | 1997-07-10 | — | — | WO | disclosed |